Phathom Pharmaceuticals (PHAT) Net Cash Flow (QoQ) (2019 - 2026)
Phathom Pharmaceuticals (PHAT) Net Cash Flow (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Phathom Pharmaceuticals | 951.79 Mn | 768.02 Mn | 46.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,082.30% |
| Dec 31, 2025 | 64.03% |
| Sep 30, 2025 | 77.03% |
| Jun 30, 2025 | 26.14% |
| Mar 31, 2025 | -127.04% |
| Dec 31, 2024 | -164.02% |
| Sep 30, 2024 | 227.05% |
| Jun 30, 2024 | 22.25% |
| Mar 31, 2024 | -135.27% |
| Dec 31, 2023 | 610.72% |
| Sep 30, 2023 | -127.53% |
| Jun 30, 2023 | 562.19% |
| Mar 31, 2023 | 37.73% |
| Dec 31, 2022 | -292.77% |
| Sep 30, 2022 | 59.63% |
| Jun 30, 2022 | 41.67% |
| Mar 31, 2022 | -8.80% |
| Dec 31, 2021 | -375.60% |
| Sep 30, 2021 | 152.81% |
| Jun 30, 2021 | 42.84% |